To cope with proteotoxic stress, cells attenuate protein synthesis. However, the precise mechanisms underlying this fundamental adaptation remain poorly defined. Here we report that mTORC1 acts as an immediate cellular sensor of proteotoxic stress. Surprisingly, the multifaceted stress-responsive kinase JNK constitutively associates with mTORC1 under normal growth conditions. On activation by proteotoxic stress, JNK phosphorylates both RAPTOR at S863 and mTOR at S567, causing partial disintegration of mTORC1 and subsequent translation inhibition. Importantly, HSF1, the central player in the proteotoxic stress response (PSR), preserves mTORC1 integrity and function by inactivating JNK, independently of its canonical transcriptional action. Thereby, HSF1 translationally augments the PSR. Beyond promoting stress resistance, this intricate HSF1-JNK-mTORC1 interplay, strikingly, regulates cell, organ and body sizes. Thus, these results illuminate a unifying mechanism that controls stress adaptation and growth.
Proteostasis is constantly challenged by environmental stressors 1 . These insults cause protein misfolding and aggregation, perturbing proteostasis and inflicting proteotoxic stress 2 . Accordingly, cells have evolved a defensive mechanism-the heat-shock, or proteotoxic stress, response (PSR) 3 .
Proteotoxic stressors induce expression of heat-shock proteins (HSPs) in cells, the hallmark of the PSR. HSPs are molecular chaperones that facilitate folding, transportation and degradation of other proteins 4 , thereby guarding the proteome against misfolding and aggregation. Through preservation of proteostasis, the PSR is essential for cells and organisms to survive deleterious environments. In mammals, heat shock factor 1 (HSF1) is the master regulator of the PSR 3 . By mounting a protective transcriptional program, HSF1 enhances cardiomyocyte survival of ischaemia/reperfusion injury, antagonizes neurodegeneration and prolongs lifespan 5 . Surprisingly, emerging studies reveal that HSF1 promotes oncogenesis [6] [7] [8] [9] [10] [11] [12] .
Beyond HSP induction, proteotoxic stressors provoke a systemic cellular response. In particular, proteotoxic stress attenuates protein translation 13 . A prominent regulator of translation is mechanistic target of rapamycin (mTOR), which forms two protein complexes, mTORC1 and mTORC2. mTORC1 senses environmental cues and governs translation by phosphorylating EIF4EBP1 (4EBP1) and p70S6K (S6K) 14 . Metabolic, hypoxic and nutritional stress inhibit mTORC1 through diverse mechanisms [15] [16] [17] [18] . In contrast, little is known of how proteotoxic stress regulates mTORC1.
Here we report that c-JUN N-terminal kinase (JNK) associates with mTORC1, poised to sense proteotoxic stress. Whereas JNK activation by proteotoxic stress disintegrates mTORC1 to suppress translation, HSF1 preserves mTORC1 activity and translation through inactivation and sequestration of JNK, thereby promoting stress resistance and growth.
RESULTS

Proteotoxic stress activates JNK and suppresses mTORC1
To pinpoint the signals triggered by proteotoxic stress to inhibit translation, we profiled signalling alterations following heat shock, a classic proteotoxic stressor. The most responsive pathway is JNK signalling (Fig. 1a) , indicated by elevated T183/Y185 phosphorylation, modifications critical to JNK activation 19 . In contrast, heat shock diminished S6K and 4EBP1 phosphorylation (Fig. 1b) .
We further examined various proteotoxic stressors, including proteasome inhibitor MG132, histone deacetylase 6 (HDAC6) inhibitor tubastatin, amino acid analogue azetidine, and HSC70/HSP70 inhibitors (VER155008 and pifithrin-µ) 3, [20] [21] [22] . Despite their diverse mechanisms of action ( Supplementary Fig. 1a ), these stressors all induced protein K48 ubiquitylation (Fig. 1c) , a modification marking Figure 1 Proteotoxic stress activates JNK signalling but suppresses mTORC1 activity. (a) Profiling heat-shock-induced alterations in major signal transduction pathways. Following heat shock at 45 • C for 30 min, lysates of HEK293T cells were incubated with phospho-antibody arrays (left). Results are presented as fold changes (right; mean of two technical replicates from one experiment, and the arrow indicates JNK1/2 T183/Y185 phosphorylation). (b,c) HEK293T cells were heat shocked at 45 • C for 30 min (b) or treated with other stressors (500 nM MG132, 10 µM tubastatin, 5 mM azetidine, 40 µM VER155008, or 20 µM pifithrin-µ) for 6 h (c). DMSO was a solvent control. (d) Fold changes in protein phosphorylation for b,c are presented as a heat map. (e,f) HEK293T cells were treated with 500 nM MG132 for the indicated times, with or without pre-treatment with 3 µM JNK-IN-8 for 60 min (mean of three wells of cells per time point per experiment; experiment was repeated twice). p-JNK and p-S6K proteins were quantified by sandwich ELISA. (g) HEK293T cells were co-transfected with AP1-SEAP (secreted embryonic alkaline phosphatase) and CMV-Gaussia luciferase (GLuc) reporter plasmids. After 24 h cells were treated with stressors as described in b,c. Reporter activities were measured 24 h later and SEAP activities were normalized against GLuc activities (mean of five wells of cells per group per experiment; this experiment was repeated twice). (h) HEK293T cells were treated with 500 nM MG132 for the indicated times and endogenous RAPTOR-mTOR interactions were examined by co-immunoprecipitation. WCL, whole-cell lysate. (i) After treatment with 500 nM MG132 or 1 µM AZD8055 for 4 h, mTOR complexes were precipitated from HEK293T cells. mTORC1 kinase activities were measured in vitro using recombinant human His-EIF4EBP1 proteins as the substrate. Phosphorylation of 4EBP1 was detected by immunoblotting. Unprocessed original scans of blots are shown in Supplementary Fig. 8 . Source data for a,e-g can be found in Supplementary  Table 1 .
proteins for proteasomal degradation 23 . This increased ubiquitylation signified perturbation of proteostasis. These stressors all triggered JNK phosphorylation and diminished phosphorylation of mTORC1 effectors ( Fig. 1b-d ), which were not due to impaired cell viability ( Supplementary Fig. 1b ). Furthermore, these two opposing events occurred simultaneously following MG132 treatment even for 10 min;
importantly, JNK-IN-8, the first irreversible JNK inhibitor 24 , both elevated the basal S6K phosphorylation and completely rescued the MG132-induced suppression ( Fig. 1e ,f). Elevated JNK phosphorylation indicated activation, evidenced by mobilization of activator protein 1 (AP1) (Fig. 1g ), a JNK-regulated transcription factor complex 25 . These results suggest a causal role of JNK activation in suppressing mTORC1 signalling. Proteotoxic stressors also induced p38 MAPK T180/Y182 phosphorylation ( Fig. 1a and Supplementary Fig. 1c ). Both p38 and JNK belong to the MAPK family and respond to stress stimuli 26 . In contrast to JNK-IN-8, SB202190, a specific p38 MAPK inhibitor 27 , did not affect MG132-induced mTORC1 suppression (Supplementary Fig. 1d ), indicating a non-causal role of p38. Blockade of MG132-induced p38 phosphorylation by SB202190 indicates p38 inactivation 27 ( Supplementary Fig. 1d ).
To assess mTORC1 integrity, we examined RAPTOR-mTOR associations 28 , by co-immunoprecipitation. We compared two celllysis conditions, 0.3% CHAPS buffer versus sonication without detergents 28, 29 . As sonication enabled more efficient co-immunoprecipitation ( Fig. 1h ), we employed this condition. In HEK293T cells, 4-h MG132 treatment disrupted RAPTOR-mTOR associations ( Fig. 1h ), a finding further supported by in vitro mTORC1 kinase assays. The ATP-competitive mTOR inhibitor AZD8055 and 4-h MG132 treatment both markedly impaired in vitro phosphorylation of recombinant 4EBP1 by immunoprecipitated mTORC1 (Fig. 1i ). These results indicate that proteotoxic stressors commonly provoke two concurrent events: JNK activation and mTORC1 inhibition.
JNK negatively regulates mTORC1, protein translation and cell size
To confirm JNK-mediated mTORC1 inhibition, we genetically blocked JNK signalling. Mammals express two ubiquitous JNK isoforms, JNK1 and 2 (ref. 25) . JNK1/2 knockdown prevented MG132induced RAPTOR-mTOR dissociations and mTORC1 suppression ( Fig. 2a and Supplementary Fig. 2a ). Transient JNK-IN-8 treatment exerted similar effects ( Supplementary Fig. 2b ), demonstrating a causative role of JNK in mTORC1 inhibition genetically and pharmacologically.
To delineate how individual JNK isoforms regulate mTORC1, we used Jnk-deficient mice. Jnk1 −/− mouse embryonic fibroblasts (MEFs) exhibited elevated basal 4EBP1 and S6K phosphorylation and mTOR S2481 autophosphorylation 30 (Fig. 2b) , indicating mTORC1 activation. Furthermore, MG132 stimulated JNK phosphorylation but reduced S6K, 4EBP1 and mTOR phosphorylation in Jnk1 +/+ MEFs, which were mitigated in Jnk1 −/− cells ( Fig. 2c ). Similar results were obtained in Jnk2 −/− MEFs (Fig. 2d ), indicating that both JNK1 and JNK2 are necessary for mTORC1 inhibition. MG132 did not evidently impair cell viability ( Supplementary Fig. 2c,d) .
To address whether JNK activation suffices to inhibit mTORC1, we expressed either a constitutively active JNK1 CA or a wild-type JNK2A2 (refs 31,32) . The results indicate the sufficiency; JNK activation, indicated by elevated c-JUN phosphorylation, impaired S6K, 4EBP1 and ULK1 phosphorylation ( Fig. 2e ). mTORC1 phosphorylates ULK1 at S757 to suppress autophagy 33 . Interestingly, JNK1 CA impaired 4EBP1 and ULK1, but not S6K, phosphorylation ( Fig. 2e ). Given that JNK1 CA is a fusion protein between JNK1 and its kinase MKK7 (ref. 32) , we reasoned that MKK7 might phosphorylate S6K independently of mTORC1, counteracting the JNK1 effect. Indeed, MKK7 knockdown impaired S6K phosphorylation ( Supplementary  Fig. 2e ). In contrast to JNK1 CA , JNK2A2 without MKK7 fusion suppressed S6K phosphorylation; and JNK-IN-8 further increased S6K phosphorylation in JNK1 CA -expressing cells ( Supplementary  Fig. 2f ), excluding potential JNK-mediated phosphorylation. Moreover, either JNK1 CA or JNK2A2 sufficed to disrupt RAPTOR-mTOR associations ( Supplementary Fig. 2g ). These results confirm JNK1/2 as an mTORC1 suppressor and reveal an unexpected MKK7-dependent S6K phosphorylation.
We next asked whether JNK impacts mTORC1-mediated translation 14 . To measure the translation rate, we employed a labelling technique that exploits the property of puromycin to covalently attach to nascent polypeptides 34 . As expected, AZD8055 reduced puromycin labelling ( Supplementary Fig. 2h ), indicating impaired translation. Conversely, JNK knockdown enhanced puromycin labelling ( Fig. 2f and Supplementary Fig. 2i ). JNK1 CA and JNK1 DN reduced and enhanced, respectively, puromycin labelling ( Fig. 2g) 19 , indicating translation suppression by JNK.
We asked whether JNK impacts the mTORC1-mediated cell-size control 35 . JNK knockdown enlarged cell size; furthermore, JNK1 CA and JNK1 DN reduced and increased, respectively, cell size ( Fig. 2h ,i). JNK1 CA failed to further reduce cell size following AZD8055 treatment ( Supplementary Fig. 2j ), suggesting that JNK acts largely through mTORC1. The negative cell-size control by JNK was confirmed in primary MEFs and mouse liver cells ( Fig. 2j,k) . Congruently, Jnk −/− mouse livers exhibited elevated mTORC1 signalling ( Fig. 2l ). Phosphorylation of S6 ribosomal protein (S6RP) was used to indicate S6K activation 36 , owing to weak S6K phosphorylation signals in tissues. Importantly, Jnk1-deficient livers exhibited heightened translation ( Fig. 2m ). mTORC1 signalling was also elevated in Jnk-deficient skin and kidneys ( Supplementary Fig. 2k ,l). We then investigated whether JNK impacts body size. Paradoxically, wild-type and Jnk-deficient mice exhibited similar body weights ( Fig. 2n and Supplementary Fig. 2m ). Given reduced fat tissues in Jnk1 −/− mice 37 , we reasoned that this might obscure mTORC1-mediated body weight increase. Revealed by body composition analyses, Jnk-deficient mice had an average 0.7 g less fat mass; in contrast, they gained an average 0.9 g lean mass ( Fig. 2o ,p and Supplementary Fig. 2n ,o). Collectively, these results indicate that JNK negatively regulates cell size and body lean mass through mTORC1 but positively regulates fat mass, probably independently of mTORC1.
JNK physically phosphorylates mTORC1
We investigated whether mTORC1 is a substrate for JNK. Several mTORC1 components, including mTOR, RAPTOR, GβL/mLST8 and PRAS40, were co-precipitated with JNK even under basal conditions ( Fig. 3a ). MG132 markedly diminished co-immunoprecipitation of mTOR and GβL/mLST8 with JNK; in contrast, co-immunoprecipitation of RAPTOR and PRAS40 with JNK remained unaltered ( Fig. 3a) , revealing their constitutive interactions. Interestingly, we did not detect interactions of JNK with RICTOR ( Fig. 3b ), a unique mTORC2 component 14 . These results indicate that JNK specifically associates with mTORC1 under non-stress conditions, and that proteotoxic stress selectively dissociates mTOR and GβL/mLST8 from this complex. Results were normalized against wild-type controls (mean ± s.d., n = 3 or 4 mice per genotype, one-way ANOVA). (l) mTORC1 signalling in livers of 6-week-old male mice was immunoblotted. (m) Two hours before collecting tissues, mice were intraperitoneally injected with 1 mg puromycin. The levels of puromycin-labelled proteins in livers were quantified by ELISA (mean ± s.d., n = 3 mice per genotype, unpaired two-tailed Student's t-test). (n-p) Whole-body weight and composition were measured in 6-weekold female mice (mean ± s.d., n = 5, 6, or 9 mice per genotype, oneway ANOVA). Statistical significance: * * P < 0.01; * * * P < 0.001; NS, not significant. Statistics source data for k,m can be found in Supplementary  Table 1 . Unprocessed original scans of blots are shown in Supplementary  Fig. 8 .
To illuminate the detailed interactions among JNK, RAPTOR and mTOR, we used the proximity ligation assay (PLA) technique, which generates signals marking close vicinity of two proteins 38 . Antibody specificities were verified by immunostaining ( Supplementary Fig. 3a (f) Following co-transfection of FLAG-mTOR, FLAG-RAPTOR and FLAG-JNK1 plasmids into HEK293T cells, RAPTOR was precipitated using anti-RAPTOR antibodies and co-precipitated mTOR and JNK1 were immunoblotted under both non-reducing and reducing conditions using anti-FLAG antibodies. FLAG signals were quantified by ImageJ software (mean ± s.d., n = 3 independent experiments). β-ME, 2-mercaptoethanol; HC, heavy chain. (g) HEK293T cells stably expressing RAPTOR-targeting shRNAs were co-transfected with the indicated plasmids. Following immunoprecipitation of HA-tagged RAPTOR, total phosphorylation of RAPTOR was immunoblotted using antiphosphoserine/threonine antibodies. RAPTOR S863 phosphorylation was directly immunoblotted using phospho-specific antibodies. (h) HEK293T cells stably expressing mTOR-targeting shRNAs were co-transfected with the indicated plasmids. Following immunoprecipitation of Myc-tagged mTOR, total and S567-specific phosphorylation of mTOR were immunoblotted using anti-phosphoserine/threonine and anti-phospho-mTOR S567 antibodies, respectively. (i,j) Exogenously expressed RAPTOR or mTOR was precipitated from HEK293T cells, and further incubated with 100 ng recombinant GST or GST-JNK1 proteins in vitro. Total and serine-specific phosphorylation of precipitated RAPTOR and mTOR were immunoblotted. (k,l) HEK293T cells depleted of endogenous RAPTOR or mTOR by stable shRNA expression were transfected with the indicated plasmids and treated with DMSO or 500 nM MG132 for 4 h. Following immunoprecipitation of exogenously expressed RAPTOR or mTOR, serine-specific phosphorylation and RAPTOR-mTOR interactions were immunoblotted. Activities of precipitated mTORC1 were measured in vitro using recombinant His-EIF4EBP1 proteins. (m) Schematic depiction of the proposed JNK-mTORC1 interactions. Unprocessed original scans of blots are shown in Supplementary Fig. 8 . detectable in HeLa cells; congruent with our immunoprecipitation results, MG132 diminished JNK1-mTOR, but not JNK1-RAPTOR, signals ( Fig. 3c,d ). PLA revealed both cytoplasmic and nuclear JNK-mTORC1 interactions ( Fig. 3c,d) , consistent with mTORC1 distribution in both compartments 39 . JNK-mTORC1 interactions differ from the well-recognized interactions between AMP-activated protein kinase (AMPK) and mTORC1. Whereas glucose deprivation activated AMPK and induced AMPK-RAPTOR associations 16 , JNK-RAPTOR interactions did not increase, despite JNK activation (Fig. 3e ). Thus, JNK-RAPTOR associations remain constant under both MG132 treatment and glucose deprivation. Next, we determined the stoichiometry of JNK-mTORC1 complexes. Through co-expression of FLAG-tagged RAPTOR, mTOR and JNK1, we precipitated RAPTOR and calculated the molecular ratio of co-precipitated JNK1 and mTOR as 1.8 to 1.0 ( Fig. 3f) . Similar results were observed for endogenous proteins ( Supplementary Fig. 3d ), suggesting that some mTORC1 contains two JNK molecules. Congruently, under non-reducing conditions we detected JNK1 dimers co-precipitated with RAPTOR and mTOR ( Fig. 3f ).
Conforming to the consensus motif S/T-Pro ( Supplementary  Fig. 3e ) 40 , two strong candidate JNK phosphorylation sites, RAP-TOR S863 and mTOR S567, were predicted. We then generated phosphorylation-resistant mutants, RAPTOR S863A and mTOR S567A . In HEK293T cells, JNK1 CA expression increased both total and S863-specific phosphorylation of RAPTOR WT , but not phosphorylation of RAPTOR S863A (Fig. 3g) . Similar results were observed for mTOR WT and mTOR S567A (Fig. 3h ), suggesting these sites as major JNK phosphorylation targets. Furthermore, in vitro purified recombinant JNK1 kinases readily phosphorylated immunoprecipitated RAPTOR WT and mTOR WT proteins, but not their mutant counterparts (Fig. 3i,j) . Importantly, incubation of JNK-IN-8, but not AZD8055, with immunoprecipitated mTORC1 and recombinant JNK1 diminished RAPTOR S863 and mTOR S567 phosphorylation but enhanced mTOR S2481 autophosphorylation ( Supplementary Fig. 3f ). These results confirm JNK as the kinase directly phosphorylating RAPTOR and mTOR.
Through JNK activation, MG132 induced RAPTOR S863 and mTOR S567 phosphorylation ( Supplementary Fig. 3g ,h). Substitution of endogenous RAPTOR or mTOR with phosphorylation-resistant mutants markedly antagonized MG132-induced dissociations and inhibition of mTORC1 (Fig. 3k,l and Supplementary Fig. 3i,j) . Together, these results indicate that JNK physically associates with mTORC1, and strongly suggest that on activation JNK disintegrates mTORC1 at least partially by phosphorylating RAPTOR and mTOR ( Fig. 3m ).
HSF1 suppresses JNK to maintain mTORC1 integrity and activity
HSF1 is pivotal to proteotoxic stress suppression and proteostasis. Previously, we uncovered defective mTORC1 signalling in Hsf1deficient cells 7 , despite the elusive underlying mechanisms. Now, we asked whether HSF1 regulates mTORC1 through JNK.
Proteotoxic stressors triggered JNK phosphorylation in immortalized MEFs carrying conditional Hsf1 fl/fl alleles ( Supplementary  Fig. 4a and Fig. 4a ). Acute Hsf1 deletion by Cre recombinase enhanced both basal and stressor-induced JNK phosphorylation, causing more severe reductions in 4EBP1 and S6K phosphorylation (Fig. 4a ). These changes were not due to impaired cell viability (Supplementary Fig. 4b ). Hsf1 −/− livers and brains also exhibited elevated JNK phosphorylation and impaired mTORC1 signalling (Fig. 4b,c ). HSF1targeting shRNAs caused similar effects in HEK293T cells; importantly, concurrent JNK knockdown alleviated mTORC1 suppression ( Fig. 4d ). Furthermore, HSF1 depletion heightened JNK1-RAPTOR interactions but disrupted RAPTOR-mTOR interactions, which were rescued by JNK-IN-8 ( Fig. 4e ). Whereas in HEK293T cells JNK1 precipitated both RAPTOR and HSF1, RAPTOR precipitated JNK1 but not HSF1 (Fig. 4f ), indicating that HSF1 is not associated with mTORC1. PLA also detected endogenous HSF1-JNK1 interactions, predominantly nuclear, in immortalized MEFs (Supplementary Fig. 4c,d ), suggesting that HSF1 sequesters JNK apart from mTORC1.
Given that HSF1 regulates HSP90α expression and HSP90 chaperones mTORC1 (ref. 41) , it remains unclear whether HSP90 is implicated in mTORC1 regulation by HSF1. Transient HSF1 depletion did not reduce HSP90 proteins in both MEFs and HEK293T cells (Figs 4a and 5a). Next, we treated HEK293T cells and MEFs with 17-DMAG, a potent HSP90 inhibitor 42 . In HEK293T cells, 17-DMAG suppressed mTORC1 signalling but inactivated JNK, strongly suggesting a JNK-independent mechanism; moreover, JNK-IN-8 markedly reversed mTORC1 suppression ( Fig. 5a ), indicating that JNK and HSP90 regulate mTORC1 through distinct mechanisms in HEK293T cells. Surprisingly, 17-DMAG activated JNK in MEFs and JNK-IN-8 fully blocked mTORC1 suppression by 17-DMAG ( Fig. 5b ), suggesting that in MEFs HSP90 regulates mTORC1 predominantly through JNK. These results highlight that HSF1 suppresses JNK to maintain mTORC1 activity, independently of HSP90.
To determine whether transcriptional activity of HSF1 is required for JNK suppression, we generated two mutants, HSF1 1−379 lacking the transactivation domain (AD) and HSF1 AD lacking the DNA-binding domain (DBD). HSF1 WT , but not these two mutants, activated an HSF1 reporter (Fig. 5c ). Like HSF1 WT , both mutants suppressed JNK activation and rescued MG132-induced mTORC1 suppression ( Fig. 5d,e ), strongly suggesting transcription independence. Both wild-type and mutant HSF1 did not evidently increase HSP90, but suppressed JNK and stimulated mTORC1 in the presence of 17-DMAG ( Fig. 5f ), confirming HSP90 independence. Interestingly, HSF1 WT , HSF1 1−379 and HSF1 AD all co-precipitated with endogenous JNK1; moreover, their overexpression diminished endogenous JNK1-RAPTOR interactions ( Supplementary Fig. 4e ). Collectively, these data support a model wherein HSF1 maintains mTORC1 integrity and activity by suppressing JNK (Supplementary Fig. 4f ).
mTORC1 translationally augments the PSR
To address whether the HSF1-sustained mTORC1 activity is beneficial under proteotoxic stress, we stimulated mTORC1 by inactivating tuberous sclerosis 1 (TSC1), a tumour suppressor negatively regulating mTORC1 (ref. 43 ). Deletion of Tsc1 in MEFs by adenoviral Cre transduction elevated S6K phosphorylation, and increased HSF1 and HSPs (Fig. 6a ). More HSF1 proteins were labelled with puromycin in Tsc1-deficient cells, indicating heightened HSF1 translation (Fig. 6b) . Accordingly, Tsc1-deficient cells were more resistant to MG132 treatment (Fig. 6c ). (f) Following immunoprecipitation of endogenous JNK1 or RAPTOR proteins from HEK293T cells, co-precipitated RAPTOR, JNK1 or HSF1 proteins were immunoblotted. Unprocessed original scans of blots are shown in Supplementary Fig. 8 .
Although total messenger RNA levels of Hsf1, Hsp72 and Hsp90α under MG132 treatment were higher in Tsc1-deficient cells, polysomal association of these mRNAs was more prominently enhanced by Tsc1 depletion (Fig. 6d,e ), supporting that higher mTORC1 activity more efficiently translates these transcripts under proteotoxic stress. Conversely, either mTOR or RAPTOR knockdown diminished HSF1 and HSPs (Fig. 6f) . Similarly, pharmacological mTORC1 inhibition suppressed HSF1 translation ( Supplementary Fig. 5 ). Furthermore, AZD8055 blocked MG132-induced HSP expression, causing more severe protein ubiquitylation and apoptosis (Fig. 6g) . These results indicate that mTORC1 translationally amplifies the PSR to promote stress resistance.
HSF1 regulates cell, organ and body size through JNK suppression
Congruent with its regulation of mTORC1, HSF1 overexpression enlarged HEK293T cells, which was markedly reversed by JNK1 CA (Fig. 7a ). Conversely, HSF1 knockdown reduced translation and cell size; and, concurrent JNK knockdown largely rescued these defects ( Supplementary Fig. 6a,b and Fig. 7b ).
To investigate whether this mechanism controls organ and body size, we generated four groups of mice: Supplementary  Table 1 . Unprocessed original scans of blots are shown in Supplementary  Fig. 8 .
rescued these defects (Fig. 7c-f and Supplementary Fig. 6c ). In mouse livers, Hsf1 deletion activated JNK but diminished mTORC1 signalling; and both were reversed by Jnk deletions (Fig. 7g) . Importantly, Hsf1 deletion did not reduce HSP90α; in contrast, HSP72 and HSP25 were markedly diminished and this reduction was not rescued by Jnk deficiency ( Supplementary Fig. 6d ). Together, these results support that in mice HSF1 regulates mTORC1 largely through JNK, independently of HSPs. Jnk deficiency also rescued size defects in Hsf1 −/− kidneys and brains ( Supplementary Fig. 6e ,f and Fig. 7h,i) . Supplementary Table 1 . Unprocessed original scans of blots are shown in Supplementary Fig. 8 .
Consistent with a previous report 44 , Hsf1 −/− mice exhibited a 20% reduction in body weight and body surface area; strikingly, deletion of either Jnk isoform largely rescued these defects in both sexes (Fig. 7j,k and Supplementary Fig. 6g-i ). Furthermore, Jnk deletions fully rescued the lean mass reduction due to Hsf1 deficiency ( Fig. 7l and Supplementary Fig. 6j ), consistent with rescue of mTORC1 suppression. Unexpectedly, Hsf1 deficiency also reduced body fat mass; however, Jnk deletions failed to rescue this defect ( Fig. 7m and Supplementary Fig. 6k ). The reduced body fat mass approximately equals the body weight not rescued by Jnk deletions.
Hsf1 −/− mice were maintained on a mixed genetic background to circumvent placental defects manifested on inbred backgrounds 44 . To exclude potential genetic modifiers, we used the inbred C57BL/6J Hsf1 fl/fl mice ( Supplementary Fig. 4a ). To achieve liver-specific Hsf1 deletion, we crossed C57BL/6J Albumin-Cre mice with Hsf1 fl/fl mice. Alb-Cre + ; Hsf1 fl/fl mice exhibited smaller liver size, reduced liver lean mass, and decreased liver cell size; surprisingly, Jnk1 haplodeficiency, but not homozygous deficiency, largely rescued these defects (Fig. 8a-d and Supplementary Fig. 7a,b ). However, Jnk1 homozygous deficiency both overly rescued mTORC1 signalling and heightened translation in Hsf1-deficient livers (Fig. 8e,f and Supplementary Fig. 7c ). Cell-size homeostasis is the consequence of coordinated cell growth and division 45 . Thus, we reasoned that altered cell proliferation might counterweigh augmented translation in Alb-Cre + ; Hsf1 fl/fl ; Jnk1 −/− livers. We observed an increased in vivo BrdU labelling during the S phase of the cell cycle in Alb-Cre + ; Hsf1 fl/fl ; Jnk1 −/− liver cells, but not in liver cells from the other three groups ( Supplementary Fig. 7d and Fig. 8g ). Congruently, c-MYC and MCM2, two known proliferation markers 46, 47 , were increased in Alb-Cre + ; Hsf1 fl/fl ; Jnk1 −/− , but not Hsf1 −/− ; Jnk1 −/− or Hsf1 −/− ; Jnk2 −/− , livers ( Supplementary Fig. 7e,f) . Also, apoptosis was enhanced in Alb-Cre + ; Hsf1 fl/fl ; Jnk1 −/− livers (Fig. 8h ), but not in Hsf1 −/− ; Jnk1 −/− livers ( Supplementary Fig. 7g ). These results support the finding that despite heightened translation, Jnk1 homozygous deficiency fails to Supplementary  Table 1 . Unprocessed original scans of blots are shown in Supplementary  Fig. 8 .
rescue reduced cell size in Alb-Cre + ; Hsf1 fl/fl livers owing to enhanced proliferation and apoptosis. Next we sought to elucidate why proliferation was stimulated in Alb-Cre + ; Hsf1 fl/fl ; Jnk1 −/− , but not Hsf1 −/− ; Jnk1 −/− , livers. In Alb-Cre + ; Hsf1 fl/fl ; Jnk1 −/− livers Hsf1 is specifically deleted in albumin-expressing hepatocytes, but not in non-parenchymal cells ( Supplementary Fig. 7h ). In contrast, Hsf1 is deleted in both cell types in Hsf1 −/− ; Jnk1 −/− livers. Therefore, HSF1 expressed in Jnk1 −/− non-parenchymal cells might produce non-cell-autonomous effects to drive Hsf1-deficient hepatocyte proliferation. We tested this using an in vitro system, wherein immortalized Hsf1 −/− MEFs were co-cultured with primary Jnk1 +/+ ; Hsf1 +/+ , Jnk1 +/− ; Hsf1 +/+ or Jnk1 −/− ; Hsf1 +/+ MEFs. Interestingly, co-culture with Jnk1 −/− ; Hsf1 +/+ , but not with the other, MEFs promoted the proliferation of Hsf1 −/− MEFs (Fig. 8i) .
To elucidate how Jnk1 −/− ; Hsf1 fl/fl non-parenchymal cells exerted mitogenic effects on Alb-Cre + ; Hsf1 fl/fl hepatocytes, we quantified the mRNA levels of a panel of growth factors known to drive hepatocyte proliferation in liver tissues. Among them, only the expression pattern Fig. 2m (mean, n = 2 mice per genotype, one-way ANOVA).
(g) Following intraperitoneal injection of 2 mg BrdU per mouse for 2 h, singleliver-cell suspensions were co-stained with propidium iodide and rat anti-BrdU antibody (mean ± s.d., n = 4 mice per genotype, one-way ANOVA). (h) Caspase 3 activity was quantified in 6-week-old male mouse livers using DEVD-R110 (mean ± s.d., n = 3 mice per genotype, one-way ANOVA). (i) Immortalized Hsf1 −/− MEFs were co-cultured with primary Jnk1 MEFs (1:1) for 48 h, and co-stained with rabbit anti-Ki-67 and mouse anti-HSF1 antibodies. Ki-67 levels of HSF1-negative cells were compared (mean ± s.d., n = 3 independent experiments, one-way ANOVA). (j) mRNAs in 6-week-old male mouse livers were quantified by qRT-PCR, two mice per genotype. Fold changes were presented as a heat map. (k) Endogenous HSF1 DNAbinding was detected by PLA as described previously 11 and quantified by flow cytometry (mean ± s.d., n = 3 independent experiments, one-way ANOVA).
(l) Following shRNA transfection, HGF mRNAs were quantified in HEK293T cells stably expressing JNK1/2-targeting shRNAs (mean, n = 3 wells of cells per group per experiment, repeated three times). (m) The binding of HSF1 to the HGF promoter was quantified by chromatin immunoprecipitation as described previously 12 Supplementary Table 1 . Unprocessed original scans of blots are shown in Supplementary Fig. 8 .
of hepatocyte growth factor (Hgf ) concurred with the proliferation state of liver cells, showing elevation in Jnk1 −/− livers but nearly normal levels in Jnk1 +/− livers (Fig. 8j ). A similar pattern was observed in primary MEFs ( Supplementary Fig. 7i ), indicating suppression of Hgf expression by JNK1. Interestingly, Jnk1-deficient MEFs exhibited increased Hsp mRNAs ( Supplementary Fig. 7j ), suggesting HSF1 activation. Furthermore, JNK1/2 knockdown promoted the binding of HSF1 to genomic DNAs (Fig. 8k ), confirming HSF1 activation by JNK deficiency. HGF mRNAs were increased in HEK293T cells with JKN1/2 knockdown; and, concurrent HSF1 knockdown blocked this increase (Fig. 8l) . Moreover, JNK deficiency enhanced the binding of HSF1 to the HGF gene promoter (Fig. 8m) , pinpointing HGF as a transcriptional target of HSF1. Consistently, Jnk1 deficiency failed to rescue diminished Hgf mRNAs in Hsf1 −/− livers ( Supplementary Fig. 7k ).
Responding to elevated HGF expression, Alb-Cre + ; Hsf1 fl/fl ; Jnk1 −/− livers showed increased phosphorylation of c-MET, the cognate HGF receptor 48 ; in contrast, c-MET phosphorylation did not increase in Hsf1 −/− ; Jnk1 −/− or Hsf1 −/− ; Jnk2 −/− livers ( Supplementary Fig. 7l,m) . HSF1 activation, evidenced by its S326 phosphorylation 12 , in nonparenchymal cells and c-MET phosphorylation in hepatocytes were confirmed in Alb-Cre + ; Hsf1 fl/fl ; Jnk1 −/− livers by immunostaining ( Fig. 8n ). Collectively, these results demonstrate that HSF1 controls organ and body size, largely through JNK-dependent mTORC1 regulation. Moreover, these results uncover an HSF1-mediated non-cellautonomous interaction between hepatocytes and non-parenchymal cells (Fig. 8o ).
DISCUSSION
Our studies delineate a mechanism whereby cells adapt protein synthesis to stress. Whereas JNK senses proteotoxic stress and directly suppresses mTORC1 to attenuate translation, HSF1 suppresses JNK to sustain translation. Importantly, this mechanism impacts stress resistance and body growth. Our studies pinpoint JNK as a central nexus linking proteotoxic stress to mTORC1. JNK, activated by various stresses, regulates transcription and apoptosis by phosphorylating numerous targets 25 . Our findings reveal that JNK constitutively associates with mTORC1; surprisingly, proteotoxic stress does not enhance JNK-RAPTOR associations ( Fig. 3a-e ), contrasting sharply with the notably induced AMPK-RAPTOR associations by metabolic stress (Fig. 3e ). Our findings indicate that JNK activation, a common cellular response to proteotoxic stress, disintegrates mTORC1 at least partially by phosphorylating RAPTOR at S863 and mTOR at S567 (Fig. 3i-l) . Whereas mTORC1 translocates to the lysosome surface in response to amino acid stimulation 49 , it also senses various other stimuli and localizes at diverse cellular compartments, including nuclei 50 . Congruently, our findings reveal both cytoplasmic and nuclear JNK-mTORC1 interactions (Fig. 3c,d) . Given JNK activation by glucose or amino acid deprivation 51, 52 , whether JNK impacts nutrientsensing by mTORC1 remains elusive. Also, whether mTORC1 regulates JNK remains unknown. In aggregate, our findings support a model wherein JNK physically associates with mTORC1 in a relatively constitutive manner. On activation by proteotoxic stress, JNK phosphorylates both RAPTOR and mTOR, causing partial mTORC1 dissociation. Thereby, mTORC1 serves as a key cellular sensor of proteotoxic stress.
Our studies uncover a transcription-independent role of HSF1 in protein translation. By inactivating and sequestrating JNK, HSF1 sustains mTORC1-mediated translation (Fig. 4) . Under our experimental conditions, HSF1 regulates mTORC1, largely independently of HSP90. First, transient HSF1 depletion or Hsf1 knockout does not reduce HSP90 (Figs 4a and 5a and Supplementary  Fig. 6d ), owing to the high abundance of HSP90 proteins under non-stress conditions and specific regulation of HSP90α isoform by HSF1 under stress 53 . Second, even with HSP90 inhibition, both wild-type and transcription-deficient HSF1s suppress JNK and activate mTORC1 (Fig. 5f ). Nonetheless, in cancer cells where HSF1 is constitutively active and HSP90 is highly demanded 54 , chronic HSF1 inhibition may deplete HSP90 to impair mTORC1 chaperoning. Of note, compared with the slow transcriptional regulation of HSP90 expression, the rapid regulation of JNK activation enables HSF1 to more efficiently control mTORC1. Surprisingly, our findings reveal context-dependent impacts of HSP90 on JNK signalling. In HEK293T cells, HSP90 inhibition inactivates JNK (Fig. 5a ), probably by destabilizing MLK3. As a JNK-activating kinase, MLK3 is chaperoned by HSP90 and overexpressed in malignant cells 55, 56 . In contrast, HSP90 inhibition activates JNK in MEFs (Fig. 5b ), suggesting that HSP90 can impact mTORC1, either indirectly through JNK or directly through its chaperoning activity, depending on cellular contexts.
Our findings highlight a key role of HSF1 in maintaining translation at an operational level appropriate for stressful conditions. Whereas mitigated global protein synthesis during stress is beneficial, unrestrained suppression would be adverse. Our studies indicate that mTORC1 controls translation of HSF1 and HSP mRNAs and, accordingly, resistance to proteotoxic stress (Fig. 6 ). By controlling mTORC1, HSF1 augments expression of itself and HSPs at the translational level. Thus, HSF1 governs the PSR both transcriptionally and translationally.
Our studies reveal that HSF1 intimately coordinates protein synthesis and folding, two processes fundamental to proteostasis. Without HSF1, cells suffer a diminished protein quality-control capacity. Despite their vulnerability to proteomic fluctuations, Hsf1deficient cells remain viable under non-stress conditions 7, 44 . Now our findings reveal that these deficient cells mitigate mTORC1-mediated translation, thereby lessening the proteomic burden to sustain their fragile proteostasis and viability. However, this adaptive strategy has striking biological consequences, diminishing cell, organ and body sizes (Fig. 7) .
Moreover, our studies uncover a non-cell-autonomous action of HSF1 in promoting proliferation through the HGF-c-MET signalling axis (Fig. 8o ). Intriguingly, JNK suppresses both mTORC1 and HSF1, highlighting a role of JNK in proteostasis. Thus, the mutual HSF1-JNK regulations finely orchestrate cellular protein quantityand quality-control machineries to ensure optimal cellular and organismal growth.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary Information is available in the online version of the paper In vitro kinase assay. For mTORC1 kinase assays, cells were washed with PBS and re-suspended in ice-cold sonication buffer without 1 mM EDTA and sonicated as described above. Total 1 mg proteins in sonication buffer supplemented with protease inhibitor cocktail were incubated with 1 µg primary antibodies and 20 µl Protein G MagBeads (GenScript) at 4 • C overnight. Precipitated beads were washed once with 500 µl high-salt kinase washing buffer (25 mM HEPES-KOH pH 7.4, 20 mM KCl, 500 mM NaCl) followed by washing with kinase washing buffer ( For JNK kinase assays, cells were lysed through sonication as described above. Total 1 mg proteins in sonication buffer supplemented with protease inhibitor cocktail were incubated with 1 µg primary antibodies and 20 µl Protein G MagBeads shRNA and siRNA knockdown. Lentiviral pLKO shRNA plasmids targeting human HSF1 were obtained from the Broad Institute RNAi platform: HSF1: TRCN0000007480 (hA6), TRCN0000007483 (hA9). Control hairpins targeting a scrambled sequence with no known homology to any human genes (Scram; 5 -CCTAAGGTTAAGTCGCCCTCG-3 ) have been described previously 7 . pLKO shRNA plasmids targeting human JNK1/MAPK8 and JNK1/MAPK9 were purchased from Dharmacon GE Healthcare: JNK1 shRNA2 (TRCN0000001056), JNK1 shRNA4 (TRCN0000010580), JNK2 shRNA1 (TRCN0000000945) and JNK2 shRNA2 (TRCN0000000946). MISSION siRNAs: JNK1 siRNA2 (SIHK1220), JNK1 siRNA3 (SIHK1221), JNK2 siRNA2 (SIHK1223), JNK2 siRNA3 (SIHK1224), MKK7 siRNA1 (SIHK1114), MKK7 siRNA2 (SIHK1115) and MKK7 siRNA3 (SIHK1116) were purchased from Sigma-Aldrich. The non-targeting siRNA control (D-001810-01) was purchased from Dharmacon GE Healthcare.
Cell viability and apoptosis assays.
Cell viability and numbers were measured in 96well microplate format using ViaCount reagents by a Guava EasyCyte flow cytometer (Millipore). Apoptosis was detected by either immunoblotting using anti-cleaved caspase 3 D175 (D3E9) antibodies (Cell Signaling Technologies) or a caspase 3 DEVD-R110 Fluorometric and Colorimetric Assay kit (Biotium).
Measurement of liver cell size.
Mechanically dissociated mouse livers in PBS supplemented with 10% FBS were squeezed through 70 µm nylon cell strainers with syringe heads. Single-cell suspensions were collected and centrifuged at 500g for 5 min. After washing three times with PBS-FBS, cells were analysed by flow cytometry and the primary cell populations were gated for size measurement based on forward scatter.
Isolation of polysome-bound mRNAs.
Following incubation with fresh media containing cycloheximide (100 µg ml −1 ) for 1 min, cells were rinsed with 10 ml cold PBS supplemented with cycloheximide. After adding 500 µl of cold polysome lysis buffer (20 mM Tris-HCl pH 7.5, 50 mM KCl, 10 mM MgCl 2 , 1 mM dithiothreitol, 100 µg ml −1 cycloheximide, and 1% Triton X-100) to the plate, cells were scraped and incubated for 10 min on ice. Following centrifugation for 10 min at 15,000g at 4 • C, 100µl supernatants were applied to Sephacryl S400 columns (Illustra MicroSpin S-400 HR, GE Healthcare Life Sciences) to isolate polysomes. Flow-through fractions were collected and mixed with 100 µl of polysome buffer and 20 µl of 10% SDS. Polysome-bound RNAs were extracted using RNA STAT-60 reagent (Tel-Test).
BrdU labelling of liver cells. Each mouse was intraperitoneally injected with 200 µl of sterile BrdU solution (10 mg ml −1 ). After 2 h, livers were collected to prepare single-cell suspensions in PBS using 40 µm cell strainers. Cells were slowly added to 70% ethanol at −20 • C with continuous vortex followed by 30-min incubation on ice. To denature DNAs, re-suspended cells were treated with 2 N HCl containing 0.5% Triton X-100 and incubated at room temperature for 30 min. After washing with PBS containing 1% BSA and 0.05% Tween-20, cells were incubated with 1:100 diluted rat anti-BrdU antibodies (clone BU1/75, MCA2060, AbD Serotec) at room temperature for 45 min followed by incubation with 1:200 diluted goat anti-rat IgG (H+L) Alexa Fluor488 conjugates (A-11006, Life Technologies). After washing, cells were stained with PBS containing 10 µg ml −1 of PI before flow cytometry analysis.
Immunofluorescence. For immunofluorescence on cultured cells, primary antibodies were diluted 1:100 in 5% normal goat serum. For immunofluorescence on frozen liver sections, anti-p-HSF1 S326 antibody was diluted 1:100 in 5% normal goat serum and further detected by CF594-conjugated anti-rabbit IgG (pseudo-coloured as grey), biotinylated anti-p-c-MET (Y1234/1235) antibody was diluted 1:50 and detected by DyLight 550-conjugated streptavidin, and DyLight 488-conjugated anti-Cre antibody was diluted 1:100. Primary antibodies were incubated overnight at 4 • C, and all conjugated secondary antibodies were diluted 1:200 in 5% normal goat serum and incubated at room temperature for 1 h. Fluorescent signals were captured using a Leica TCS SP5 confocal microscope and images of different fluorescence channels were overlaid using the ImageJ software.
Chromatin immunoprecipitation (ChIP). ChIP experiments were performed as described previously 11 using rabbit anti-HSF1 antibodies (H-311, Santa Cruz Biotechnology) or normal rabbit IgG. The sequences of individual primers for ChIP-qPCR are listed in Supplementary Table 3 .
Image analysis. Immunoblotting signals were quantified by ImageJ software.
Animal studies. C57BL/6 Jnk1 and Jnk2 heterozygous mice 57, 58 were obtained from The Jackson Laboratory. Hsf1 +/− mice were maintained on a mixed 129SvJ/BALB/cJ background 44 . Compound F2 mutant mice of both Hsf1 and Jnk genes were intercrossed to generate progenies for analyses. C57BL/6J Hsf1 fl/fl mice were generated by homologous recombination. A targeting vector was constructed to contain a 3,648 bp 5 homology arm, loxP-flanked Hsf1 exon2-9, a FRT flanked PGK-neo cassette, and a 3,580 bp 3 homology arm. The linearized targeting vector was electroporated into B6(Cg)-Y c−2J /J (albino C57BL/6J) embryonic stem cells. Correctly targeted embryonic stem cells were microinjected into C57BL/6J blastocysts. Chimaeras were backcrossed to C57BL/6J mice to achieve germline transmission. To remove the PGK-neo cassette, C57BL/6J Rosa26-FLP1 knock-in mice (The Jackson Laboratory) were crossed with Hsf1 fl/fl mice. Genotyping was performed by PCR using tail genomic DNAs. The genotyping primers are: P 1 (5 -GGGTATGGGGGACTTTT AGG-3 ), P 2 (5 -AGTGAGGCCCATGTAACCAG-3 ) and P 3 (5 -TCCTCCTCCC TCCCAAGTGGG-3 ). C57BL/6J Rosa26-CreER T 2 mice 59 , C57BL/6J Albumin-Cre mice 60 and Tsc1 fl/fl mice 61 on a mixed background were obtained from The Jackson Laboratory. All mouse experiments were performed under a protocol approved by The Jackson Laboratory Animal Care and Use Committee.
Measurement of global protein translation in vitro and in vivo.
Cells were incubated with 6-FAM-dC-puromycin (50 nM, Jena Bioscience) in vitro for 1 h and analysed by flow cytometry. For in vivo puromycin labelling, mice were intraperitoneally injected with 100 µl puromycin (10 mg ml −1 ) 2 h before collecting tissues. Puromycin-labelled proteins in mouse tissues were quantified by direct ELISA using anti-puromycin antibodies (clone 3RH11, no. EQ0001, KeraFast). HSF1 protein translation. Cells were labelled with biotin-dC-puromycin (100 nM, Jena Bioscience) for 3 h and cell lysates were incubated in microtitre plates coated with a cocktail of HSF1 antibodies (H-311, E-4, and 10H8, Santa Cruz Biotechnology) overnight at 4 • C. After washing, captured puromycin-labelled HSF1 proteins were detected using streptavidin-HRP conjugates (GenScript).
Nuclear magnetic resonance (NMR)-based body composition analysis.
Body composition of live mice was measured using an EchoMRI-130 whole-body composition analyser (EchoMRI LLC) according to the manufacturer's instructions.
Statistics and reproducibility.
All statistical analyses were performed using Prism 6.0 (GraphPad software). Unpaired two-tailed Student's t-test was used to compare two groups; and an F-test was used to determine equality of variances. One-way or two-way ANOVA was used to compare multiple groups. Sample sizes are listed in the figures or figure legends. All results are presented as mean ± s.d., unless otherwise noted. No statistical method was used to predetermine sample size. No samples or animals were excluded from the analyses. The experiments were not randomized. For animal studies, owing to the necessity of genotyping, the investigators were not blinded to allocation during experiments and outcome assessment.
The in vivo mouse studies (Figs 2k,m-p, 7c-f,h-m and 8a-d,g,h, and Supplementary Figs 2m-o, 6c ,e-k and 7a,b) are the sum results accumulated from at least three individual mice and Fig. 8f is the sum result of two individual mice. Figure 8i ,k is the sum result of three independent experiments. Among the representative images: Figs 1b,c,h,i, 2a-j,l, 3a-l, 4a-f, 5a,b,e,f, 6a,f,g, 7g and 8e,n and Supplementary Figs 1c,d, 2a ,b,e-l, 3f-j, 4d,e, 6a,b,d and 7e,f,l,m have been reproduced at least three times; and Supplementary Figs 3a-d, 4c and 7h have been reproduced two times. All of the other experiments have been reproduced at least two times, except Fig. 1a and Supplementary Figs 1b, 2c,d and 4b , which are from one experiment.
